BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2697425)

  • 1. The use of growth factors in severe aplastic anaemia (SAA).
    Hinterberger W; Hoffmann S; Bettelheim P; Geissler K; Maurer D; Muhm M
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():129-30. PubMed ID: 2697425
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological molecules in the treatment of hematological disorders.
    Kurzrock R; Talpaz M; Gutterman U
    Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor and myelodysplastic syndromes.
    N Engl J Med; 1988 Jul; 319(1):51-3. PubMed ID: 3288869
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.
    Ganser A; Ottmann OG; Hoelzer D
    Stem Cells; 1993 Nov; 11(6):465-73. PubMed ID: 8111306
    [No Abstract]   [Full Text] [Related]  

  • 5. Theoretical and practical issues concerning the use of rhGM-CSF and rhIL-3: present status.
    Jones TC
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():36-7. PubMed ID: 2180518
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.
    Antin JH; Smith BR; Holmes W; Rosenthal DS
    Blood; 1988 Aug; 72(2):705-13. PubMed ID: 3042046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of myelodysplastic syndromes].
    Hotta T
    Rinsho Ketsueki; 1990 Apr; 31(4):416-30. PubMed ID: 1696325
    [No Abstract]   [Full Text] [Related]  

  • 11. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow failure and hematopoietic growth factors.
    Douer D
    Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe idiopathic congenital aplastic anemia: role of hematopoietic growth factors.
    Vermylen C; Cornu G; DeWitte M; Heremans MT; Ninane J; Brichard B
    Bone Marrow Transplant; 1993 Oct; 12(4):413-5. PubMed ID: 8275043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors].
    Takaku F
    Nihon Rinsho; 1988 May; 46(5):1105-11. PubMed ID: 2457722
    [No Abstract]   [Full Text] [Related]  

  • 18. [Colony-stimulating activities of serum from patients with severe aplastic anemia].
    Zheng Y; Chu Y; Shao Z; Wang Y; Yang P; Tian Z; Tang X; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):173-6. PubMed ID: 15622760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].
    Kitamura K; Asano S; Mizoguchi H; Takaku F
    Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of colony-stimulating factors in primary hematologic disorders.
    Nimer SD
    Cancer; 1992 Aug; 70(4 Suppl):921-7. PubMed ID: 1638464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.